Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trovafloxacin: an overview

K W Garey1, G W Amsden

  • 1Department of Pharmacy, Bassett Healthcare, Cooperstown, New York 13326, USA.

Pharmacotherapy
|January 23, 1999
PubMed
Summary

Trovafloxacin is a new broad-spectrum antibiotic effective against various infections. It offers convenient oral or IV dosing and good tissue penetration, simplifying treatment regimens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020-2021.

Antimicrobial agents and chemotherapy·2023
Same author

Colitis caused by Clostridioides difficile infection in a domestic dog: A case report.

Anaerobe·2022
Same author

Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain.

Anaerobe·2020
Same author

Characterization of Clostridioides difficile ribotypes in domestic dogs in Rio de Janeiro, Brazil.

Anaerobe·2019
Same author

Multicentre derivation and validation of a simple predictive index for healthcare-associated Clostridium difficile infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Evaluation of a shoe sole UVC device to reduce pathogen colonization on floors, surfaces and patients.

The Journal of hospital infection·2017

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Antimicrobial Agents

Background:

  • Trovafloxacin is a novel synthetic naphthyridine fluoroquinolone antibiotic.
  • It has received FDA approval for treating diverse infections.

Purpose of the Study:

  • To review the characteristics and applications of trovafloxacin.
  • To highlight its role in monotherapy for complex infections.

Main Methods:

  • Review of clinical data and pharmacological properties of trovafloxacin.
  • Analysis of its spectrum of activity, pharmacokinetics, and safety profile.

Main Results:

  • Broad-spectrum activity against aerobic and anaerobic pathogens.
  • Rapid absorption, good tissue penetration, and once-daily dosing.
  • Hepatic metabolism with dosage adjustments for severe hepatic dysfunction.

Conclusions:

  • Trovafloxacin offers a beneficial option for oral or IV monotherapy.
  • It can replace multidrug regimens for certain indicated infections.
  • Potential for transient dizziness in young women is noted; interactions with antacids and iron supplements should be avoided.

Related Experiment Videos